Go to home page - PHARMAC - Pharmaceutical Management Agency
Leading Edge Medicines Management home

This is the text extract for 2011-09 Schedule Dispatch, browse documents here.


18 August 2011 August 2011 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the September 2011 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50) to change or remove your contact details. New listings  Pravastatin (Cholvastin) tab 20 mg (p’code 2362295), and 40 mg (p’code 2362309 ) – Special Authority – Retail Pharmacy  Candesartan (Candestar) tab 4 mg (p’code 2380404), 8 mg (p’code 2380412), 16 mg (p’code 2380420) and 32 mg (p’code 2380439) – Special Authority – Retail pharmacy – maximum daily doses apply  Finasteride (Rex Medical) tab 5 mg (p’code 2219883) – Special Authority – Retail pharmacy  Levothyroxine (Synthroid) tab 100 μg, 90 tab pack (p’code 2389460)  Terbinafine (Dr Reddy’s Terbinafine) tab 250 mg (p’code 2387735)  Mefenamic acid (Ponstan) cap 250 mg, 50 cap pack (p’code 2389444) – additional subsidy by Special Authority – Retail pharmacy  Bicalutamide (Bicalaccord) tab 50 mg (p’code 2387743) – Special Authority – Retail pharmacy Changes to restrictions o Budesonide (Entocort CIR) cap 3 mg – amended Special Authority criteria o Benzylpenicillin sodium (Penicillin G) inj 600 mg – amended presentation description o Adalimumab inj 40 mg per 0.8 ml prefilled pen and syringe (HumiraPen and Humira) – amended Special Authority criteria o Etanercept (Enbrel) inj 25 mg, and 50 mg autoinjector and prefilled syringe – amended Special Authority criteria o Olanzapine (Zyprexa) tab 2.5 mg, 5 mg and 10 mg – Special Authority removed o Olanzapine (Zyprexa Zydis) wafer 5 mg and 10 mg – Special Authority removed o Thalidomide cap 50 mg (Thalidomide Pharmion and Thalomid) and cap 100 mg (Thalomid) – removal of only on a controlled drug form Decreased subsidy

Chemical Calcium carbonate Fludarabine phosphate Imiquimod Olanzapine Presentation Tab eff 1. 75 g (1 g elemental) Inj 50 mg for ECP Crm 5% Tab 2.5 mg Tab 5 mg Tab 10 mg Fully subsidised brands Calsource Baxter Aldara Olanzine Dr Reddy’s Olanzapine Olanzine Dr Reddy’s Olanzapine Olanzine Dr Reddy’s Olanzapine Partially subsidised brands

Zyprexa Zyprexa Zyprexa

A447569 - qA19574


Chemical Olanzapine

Presentation Wafer 5 mg Wafer 10 mg

Fully subsidised brands Olanzine Dr Reddy’s Olanzapine Olanzine Dr Reddy’s Olanzapine

Partially subsidised brands Zyprexa Zydis Zyprexa Zydis

Increased subsidy

Chemical Acetazolamide Aminophylline Amoxycillin Presentation Tab 250 mg Inj 25 mg per ml, 10 ml Inj 250 mg Inj 500 mg Inj 1 g Inj 600 mg Tab 15 mg Powder Oral liq 1 mg per ml Crm 1%, 20 g OP Inj 1 g Inj 2 g Inj 500 μg per ml, 1 ml Inj 250 mg Inj 500 mg Inj 1 g Crm 1%, 500 g Powder, 25 g Inj 20 mg, 1 ml Cap 250 mg Tab 100 mg Inj 5 mg per ml, 1 ml Inj10 mg per ml, 1 ml; Inj 15 mg per ml, 1 ml Inj 30 mg per ml, 1 ml Fully subsidised brands Diamox DBL Aminophlline Ibiamox Ibiamox Ibiamox Sandoz DBL Leucovorin Calcium Polycal Cetirizine – AFT Clomazol Endoxan Endoxan DBL Ergometrine Flucloxin Flucloxin Flucloxin Pharmacy Health ABM Buscopan Douglas De-Worm DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate DBL Morphine Sulphate Multichem Primolut N DBL Pethidine Hydrochloride DBL Pethidine Hydrochloride Cilicaine Pinetarsol Pinetarsol Normison g Zincaps

Benzylpenicillin sodium (Penicillin G) Calcium folinate Carbohydrate supplement Cetirizine hydrochloride Clotrimazole Cyclophosphamide Ergometrine maleate Flucloxacillin sodium

Hydrocortisone Hydrocortisone Hyoscine n-butylbromide Lithium carbonate Mebendazole Morphine sulphate

Miconazole nitrate Norethisterone Pethidine hydrochloride

Crm 2%, 15 g OP Tab 5 mg Inj 50 mg per ml, 1 ml Inj 50 mg per ml, 2 ml Procaine penicillin Inj 1.5 mega u Tar with triethanolamine lauryl sulphate and Soln 500 ml fluorescein Soln 1,000 ml Temazepam Tab 10 mg Zinc sulphate Cap 137.4 mg (50 elemental)

NB. For further details and magnitude of the above subsidy changes, please consult the online version of the Update to the Pharmaceutical Schedule at: www.pharmac.govt.nz/healthpros/Schedule.

A447569 - qA19574

Metadata

Title

2011-09 Schedule Dispatch

Abstract

18 August 2011 August 2011 Pharmaceutical Schedule Dispatch This document is provided to pharmacists as an early notification of the changes to be announced in the September 2011 Update to the Pharmaceutical Schedule. Please notify PHARMAC (0800 66 00 50)…

Page 1

icon

Note

This text has been extracted from the source PDF document.

Also available as plain text.

Please contact webmaster to discuss alternative format options.